At the heart of our success lies our strategy: Preserve, Consolidate, Accelerate. In FY24, we focused on ensuring business continuity and preserving value in the business that we had acquired. This is vividly captured in the theme of the Annual Report FY24 -- ‘The Integration Effect: Building Momentum’ To make the design aesthetically vibrant, the ‘Integration’ is visually symbolized with an interesting combination of infinity motifs that come together to form a globe representing the global reach of the new world of Biocon Biologics. Our focus in the coming year now shifts to Consolidate the business and to Accelerate as we look to make a meaningful difference to healthcare and millions of patients’ lives across the world. Click on the link to know more: https://bit.ly/BBLIAR2024 #IntegratedReport #BioconBiologics #FY24
Biocon Biologics
Biotechnology Research
Bengaluru, Karnataka 440,210 followers
Transforming Healthcare. Transforming Lives.
About us
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics
- Website
-
http://www.bioconbiologics.com
External link for Biocon Biologics
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Bengaluru, Karnataka
- Type
- Privately Held
- Founded
- 1978
Locations
-
Primary
Hosur Road
Bengaluru, Karnataka 560100, IN
-
16 GREAT QUEEN STREET
Employees at Biocon Biologics
Updates
-
Biocon Biologics reposted this
#Biocon Foundation, the CSR arm of Biocon Group, in collaboration with the Indian Institute of Science (IISc), proudly hosted the 5th #OralCancerTaskForce (OCTF) Conference on July 26-27, 2024. This two-day event at the IISc campus, marking World Head & Neck Cancer Day, centered on 'Artificial Intelligence in Oral Cancer.' The conference united clinicians and scientists to discuss breakthroughs in oral cancer screening and early detection. For nearly a decade, Biocon Foundation's Oral Cancer Control Program (OCCP) has been dedicated to early detection in underserved communities, screening over 85,000 individuals across India, with 13% identified as positive for Oral Potentially Malignant Disorders (OPMDs). Biocon Foundation has partnered with IISc on the AI-Center of Excellence in Oral Cancer Projects, a multicentric study with 28 consortium partners. As the lead expert for phase 1, we're developing Aarogya Aarohan, an AI-assisted mobile phone-based white light imaging system to classify oral lesions as high-risk or low-risk for oral cancer. This project underscores the transformative role of #AI in #healthcare. Read more: https://bit.ly/3yBVgea
-
We are thrilled to announce that the Biocon Biologics Environment Health & Safety team has been honored with the EHS Best Practices Global Award by the Greentech Foundation. The award is a testament to our commitment to the highest safety standards. The 1st Annual Greentech Global EHS Awards & Summit 2024 was held in Bangkok, Thailand. Hari krishnan, Senior Manager, EHS, and Shanmugam S, Senior Director, DS Engineering, received the award on behalf of Biocon Biologics. We were chosen among 100 companies for the award that recognizes exceptional efforts in creating safer, healthier, and more sustainable workplaces.
-
Matt Erick , Chief Commercial Officer of Advanced Markets at Biocon Biologics, was recently interviewed for Pharmaceutical Executive about the evolution of the biosimilars market, therapeutics that have the most potential for growth, the role global manufacturers and biosimilars players have in providing solutions, and more. The Future of Biosimilars: Q&A with Matt Erick (pharmexec.com) #Biosimilars #BioconBiologics #BioconLeadership Read More:
-
We brought home an award in DE&I from HR ASSOCIATION OF INDIA for our dedication to creating inclusive spaces across Biocon Biologics! We are thrilled to be recognized as a Champion of Diversity, Equity & Inclusion for making a difference and driving progress. Learn more about how our organization is driving affordable access to biosimilars medication across the world: https://lnkd.in/gpUaEKet
✨ Congratulations to Biocon Biologics for winning the DE&I Award! 🏆🎉 Your outstanding commitment to diversity, equity, and inclusion is truly commendable. We celebrate this remarkable achievement and applaud your continued efforts in fostering an inclusive environment. 👏 #DEIAwards #ChampioningInclusion #DiversityMatters #EquityForAll #InclusiveSpaces #CelebratingSuccess #DrivingProgress #RemarkableOrganizations #MakingADifference #InclusionWins #DiversityEquityInclusion #InclusionRevolution #InclusionChampions #TogetherWeRise Shreehas Tambe Naveen Narayanan Chella Pandian Pitchai Dr. Ankita Singh Peterson Pereira Shyam Gor Neha jagnani Heena K.A. Faizal Patel Hiral Doshi Bhavik Vadgama bhaumik shah Chirag Darji Manish Ahuja Nidhi Gajjar Karan Pandya Vishal Gandhi Utsav Pandey Rahul Shimpi 💎 Sandra Fernandes Ayushi Joshi
-
-
#Hyderabad - we're hiring in your city for positions in our Bangalore facilities! Biocon Biologics is growing rapidly across the world and is one of the top biosimilars producers in the world today. If you fit the qualifications & experience required for the roles listed here, please scan the code to register for this walk-in drive in #Hyderabad on Sunday, August 4th! We look forward to meeting you there. Learn more about us here: www.bioconbiologics.com #BioconBiologics #Hiring #Biosimilars #Healthcare
-
-
Celebrating Excellence ! We had an amazing time at our 3rd Group COE Annual Awards Ceremony 2024 on July 5th at Tyler Jacks Auditorium, Biocon Park. It was a fantastic event organized by the Group COE team led by Parth S. and his team Piyush Soni Ritwick Tandon Anil Kumar Chilagani Rohit Kurup & Umang Kaushik where we recognized and celebrated our employees' incredible achievements. Awards were given out in categories of Lean Six Sigma Black Belt, Green Belt and Yellow Belt projects, Best Kaizens generated, 5S implementation and Biocon’s very own John Shaw Excellence Model. Kiran Mazumdar Shaw, our Executive Chairperson, was the Guest of Honor and gave an inspiring speech. We had 400 employees join us in person and over 1300 virtually! Our leadership team from Biocon, Biocon Biologics , and Syngene International Limited were all there to support and congratulate the winners. We also had a special episode of the Utkarsh Leadership Talk Series powered by Group COE with Kiran Mazumdar Shaw and Soumitra Bhattacharya CEO and Executive Director, IFQM (Indian Foundation for Quality Management) sharing their insights on business excellence. Congrats to all the winners and participants! Your hard work and dedication are truly inspiring. 🌟 #BioconBiologics #AnnualAwards #Excellence #Teamwork #Celebration #biocongroup #syngene Kiran Mazumdar Shaw Siddharth Mittal Shreehas Tambe Naveen Narayanan Maninder Kapoor Puri Rhonda Duffy Sandeep Athalye Alok Mehrotra Kenneth Barr, Ph.D. Vishal Nayyar Anuj Goel Amit Kaptain Syngene International Limited Biocon
-
-
-
-
-
+4
-
-
The U.S. Food and Drug Administration (US FDA) recently approved Biocon Biologics’ first-to-file application for Yesafili™ (aflibercept-jbvf), which is intended for the treatment of age-related macular degeneration and visual impairment. It was the Company’s expansion into the ophthalmology therapeutic area in the United States. --- FDA-approved biosimilars are safe and effective treatment options that could provide immense savings on lifesaving medications. Learn more on the @FDA’s website here: https://lnkd.in/dHZFzaq
FDA-approved biosimilars are safe and effective treatment options that could provide immense savings on lifesaving medications. Learn more on the FDA's website here: https://lnkd.in/dHZFzaq
-
-
For a company that is nearly half a century old, straddling two millenia, multiple eras of socio-economic development, and rapidly changing worlds of work, to celebrate 79 people who have spent 10, 15, and 20 years working with us is priceless. Once more we felicitated the dedication, commitment and passion for purpose of our long-service colleagues who have stayed the course & grown with Biocon Biologics, like family. Even our CEO & MD - Shreehas Tambe - celebrated 27 years with us, this year! Kiran Mazumdar Shaw - our Chairperson - called it a demonstration of endurance - the most important quality needed in deep & impactful science. Our in-house talent wowed the audience with percussion, dance, and even their MC-skills! We closed the momentous occasion with an emotional ribbon unfurling ceremony - from our leaders hands through our people's hands - that signified the deep ties each of us has to the intrinsic DNA of our organization - in the work we do, the passion we do it with, and the patients for whom we do it - our North Star - across the world. We are proud of our long service colleagues and look forward to this event, celebrating them, every year. Learn more about our legacy and the milestones our teams have achieved through the years: https://lnkd.in/g5B7Jct
-
-
-
-
-
+2
-
-
We were deeply honored to host the Honourable Prime Minister of Malaysia, Dato' Seri Anwar Ibrahim , at Biocon Biologics’ booth during the #NationalBioeconomyShowcase2024. His visit underscored the significance of our mission to transform lives globally through innovative healthcare solutions. The Prime Minister's keen interest in our work to combat diabetes highlights the critical impact of our efforts. At Biocon Biologics, we are dedicated to pioneering advancements that enable better health outcomes for millions of patients worldwide. Our commitment to excellence and innovation continues to drive us forward, as we strive to make a meaningful difference in the lives of those affected by diabetes. Learn more about our journey and initiatives at Biocon Biologics Malaysia: https://lnkd.in/gG2uaXsP